Platinum-Based Neoadjuvant Chemotherapy for Breast Cancer With BRCA Mutations: A Meta-Analysis

BACKGROUND: Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer and the major phenotype of BRCA related hereditary breast cancer. Platinum is a promising chemotherapeutic agent for TNBC. However, its efficacy for breast cancer with BRCA germline mutation rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chang-Jun, Xu, Ying, Lin, Yan, Zhu, Han-Jiang, Zhou, Yi-Dong, Mao, Feng, Zhang, Xiao-Hui, Huang, Xin, Zhong, Ying, Sun, Qiang, Li, Cheng-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693629/
https://www.ncbi.nlm.nih.gov/pubmed/33304851
http://dx.doi.org/10.3389/fonc.2020.592998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693629/
https://www.ncbi.nlm.nih.gov/pubmed/33304851
http://dx.doi.org/10.3389/fonc.2020.592998

Ejemplares similares